1
|
Charnley GE, Alcayna T, Almuedo-Riera A, Antoniou C, Badolo A, Bartumeus F, Boodram LL, Bueno-Marí R, Codeço C, Codeço Coelho F, Costa F, Cox H, Haddad N, Hamid NA, Kittayapong P, Korukluoğlu G, Michaelakis A, Maciel-de-Freitas R, Montalvo T, Muñoz J, Oliveras SS, Palmer JR, Barboza Pizard CJ, Ribeiro GS, Lowe R. Strengthening resilience to emerging vector-borne diseases in Europe: lessons learnt from countries facing endemic transmission. THE LANCET REGIONAL HEALTH. EUROPE 2025; 53:101271. [PMID: 40247854 PMCID: PMC12002787 DOI: 10.1016/j.lanepe.2025.101271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/28/2024] [Revised: 02/27/2025] [Accepted: 03/05/2025] [Indexed: 04/19/2025]
Abstract
Emerging vector-borne diseases (VBDs) are a major public health concern worldwide. Climate change, environmental degradation and globalisation have led to an expansion in the range of many vectors and an erosion of transmission barriers, increasing human exposure to new pathogens and the risk for emerging VBD outbreaks. Europe is potentially underprepared for the increasing threat of VBDs, due to attention and funding being diverted to other public health priorities. Proactive, rather than reactive, prevention and control approaches can greatly reduce the socio-economic toll of VBDs. Endemic countries globally have decades of experience in controlling VBDs, and Europe has much to learn from this knowledge. Here, we advocate for the expansion of transdisciplinary knowledge-sharing partnerships, to co-create proactive measures against VBDs. We present the experiences and expertise of our diverse international team and explore how an array of interventions can be applied and adapted to the European context.
Collapse
Affiliation(s)
- Gina E.C. Charnley
- Barcelona Supercomputing Center (BSC), Barcelona, Spain
- School of Public Health, Imperial College London, London, United Kingdom
| | - Tilly Alcayna
- Barcelona Supercomputing Center (BSC), Barcelona, Spain
- London School of Hygiene & Tropical Medicine, London, United Kingdom
- Red Cross Red Crescent Climate Centre, The Hague, the Netherlands
| | - Alex Almuedo-Riera
- Barcelona Institute for Global Health (ISGlobal), Universitat de Barcelona, Barcelona, Spain
- International Health Department, Hospital Clínic de Barcelona, Barcelona, Spain
| | | | - Athanase Badolo
- Laboratoire d’Entomologie Fondamentale et Appliquée, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso
| | - Frederic Bartumeus
- Centre for Advanced Studies of Blanes (CEAB-CSIC), Girona, Spain
- Catalan Institution for Research & Advanced Studies (ICREA), Barcelona, Spain
| | - Laura-Lee Boodram
- The Caribbean Public Health Agency, Port of Spain, Trinidad & Tobago
| | - Rubén Bueno-Marí
- European Vector Control Center of Excellence, Rentokil Initial, Madrid, Spain
- Parasites and Health Research Group, Department of Pharmacy, Pharmaceutical Technology and Parasitology, Faculty of Pharmacy, University of Valencia, Burjassot, València, Spain
| | - Claudia Codeço
- Programa de Computação Cientifica, Fiocruz, Rio de Janeiro, Brazil
| | | | - Federico Costa
- Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brazil
| | - Horace Cox
- The Caribbean Public Health Agency, Port of Spain, Trinidad & Tobago
| | - Nabil Haddad
- Medical Laboratory Sciences Program, Division of Health Professions, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon
| | - Nurulhusna Ab Hamid
- Institute for Medical Research, National Institutes of Health, Ministry of Health, Malaysia
| | - Pattamaporn Kittayapong
- Center of Excellence for Vectors and Vector-Borne Diseases, Faculty of Science, Mahidol University, Nakhon Pathom, Thailand
| | - Gülay Korukluoğlu
- University of Health Sciences, Ankara Bilkent City Hospital, Türkiye
| | | | - Rafael Maciel-de-Freitas
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
- Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil
| | - Tomas Montalvo
- Agència de Salut Pública de Barcelona, Barcelona, Spain
- CIBER Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain
| | - Jose Muñoz
- Barcelona Institute for Global Health (ISGlobal), Universitat de Barcelona, Barcelona, Spain
| | | | | | | | - Guilherme S. Ribeiro
- Instituto Gonçalo Moniz, Fiocruz, Salvador, Brazil
- Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil
| | - Rachel Lowe
- Barcelona Supercomputing Center (BSC), Barcelona, Spain
- London School of Hygiene & Tropical Medicine, London, United Kingdom
- Catalan Institution for Research & Advanced Studies (ICREA), Barcelona, Spain
| |
Collapse
|
2
|
Kasbergen LMR, de Bruin E, Chandler F, Sigfrid L, Chan XHS, Hookham L, Wei J, Chen S, GeurtsvanKessel CH, Scherbeijn S, Charrel RN, Ayhan N, Lee JL, Corman VM, Reusken C, Loens K, Popescu CP, Lupse M, Briciu V, Văsieşiu AM, Pipero P, Harxhi A, Puca E, Ponosheci Biçaku A, Travar M, Ostojić M, Baljic R, Arapović J, Ledina D, Cekinović Grbeša Đ, Čabraja I, Kurolt IC, Halichidis S, Birlutiu V, Dumitru IM, Moroti R, Barac A, Stevanovic G, Pyrpasopoulou A, Koulouras V, Betica Radić L, Papanikolaou MN, Roilides E, Markotić A, Galal U, Denis E, Goodwin L, Turtle L, Florescu SA, Ramadani H, Goossens H, Ieven M, Drosten C, Horby PW, Sikkema RS, Koopmans MPG, PREPARE MERMAIDS ARBO investigator group. Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational study. THE LANCET. INFECTIOUS DISEASES 2025; 25:678-689. [PMID: 39987930 DOI: 10.1016/s1473-3099(24)00654-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Collaborators] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/17/2024] [Revised: 09/06/2024] [Accepted: 09/24/2024] [Indexed: 02/25/2025]
Abstract
BACKGROUND Arboviruses are increasingly affecting Europe, partly due to the effects of climate change. This increase in range and impact emphasises the need to improve preparedness for emerging arboviral infections that often co-circulate and might have overlapping clinical syndromes. We aimed to strengthen surveillance networks for four clinically relevant arboviruses in southeast Europe. METHODS This study reports an in-depth analysis of the MERMAIDS-ARBO prospective observational study in adults (ie, aged ≥18 years) hospitalised with an arbovirus-compatible disease syndrome in 21 hospitals in seven countries in southeast Europe over four arbovirus seasons (May 1-Oct 31, 2016-19) to obtain arbovirus prevalence outcomes. The main objectives of the MERMAIDS-ARBO study, describing the clinical management and outcomes of four arboviruses endemic to southeast Europe, including Crimean-Congo haemorrhagic fever virus (CCHFV), tick-borne encephalitis virus (TBEV), Toscana virus, and West Nile virus (WNV), are reported elsewhere. In this analysis, given the challenges associated with arbovirus diagnostics, we developed a diagnostic algorithm accounting for serology outcomes and sample timing to study arbovirus prevalence in southeast Europe. Serum samples were collected on days 0, 7, 28, and 60 after hospital admission and tested for anti-CCHFV IgG and IgM antibodies with ELISAs (confirmed with an indirect immunofluorescence test) and for IgG and IgM antibodies specific to TBEV, Toscana virus, and WNV with custom-printed protein microarrays (confirmed with virus neutralisation tests). All acute-phase samples were tested by PCR for all four viruses. Descriptive analyses were performed for virus-reactive cases by geography and year, and possible factors (eg, age, sex, and insect bites) associated with virus reactivity were assessed. FINDINGS Of 2896 individuals screened, 913 were eligible for inclusion, of whom 863 (514 men, 332 women, and 17 unknown) had samples sent to the study reference laboratories and were included in molecular and serological analyses. Some individuals had insufficient clinical data to be included in the clinical analysis, but met the eligibility criteria for and were included here. Serum sampling was incomplete (eg, samples missing from one or more timepoints or no data on time since symptom onset) for 602 (70%) patients, and the timing of collection was often heterogeneous after symptom onset up to 40 days (average median delay of 5-6 days across all timepoints), affecting the ability to diagnose arbovirus infection by serology. By use of an interpretation table incorporating timing and completeness of sampling, one (<1%) participant had a confirmed recent infection with CCHFV, ten (1%) with TBEV, 40 (5%) with Toscana virus, and 52 (6%) with WNV. Most acute confirmed infections of Toscana virus were found in Albania (25 [63%] of 40), whereas WNV was primarily identified in Romania (36 [69%] of 52). Albania also had the highest overall Toscana virus seropositivity (168 [60%] of 282), mainly explained by patients confirmed to be exposed or previously exposed (104 [62%] of 168). Patients without antibodies to WNV or Toscana virus were significantly younger than patients with antibodies (mean difference -8·48 years [95% CI -12·31 to -4·64] for WNV, and -6·97 years [-9·59 to -4·35] for Toscana virus). We found higher odds of Toscana virus reactivity in men (odds ratio 1·56 [95% CI 1·15 to 2·11]; p=0·0055), WNV reactivity with mosquito bites versus no mosquito bites (2·47 [1·54 to 3·97]; p=0·0002), and TBEV reactivity with tick bites versus no tick bites (2·21 [1·19 to 4·11]; p=0·018). INTERPRETATION This study shows that despite incomplete and heterogeneous data, differential diagnosis of suspected arbovirus infections is possible, and the diagnostic interpretation algorithm we propose could potentially be used to strengthen routine diagnostics in clinical settings in areas at risk for arboviral diseases. Our data highlight potential hotspots for arbovirus surveillance and risk factors associated with these particular arbovirus infections. FUNDING European Commission and Versatile Emerging infectious disease Observatory. TRANSLATIONS For the Greek, Albanian, Romanian, Bosnian, Serbian, and Croatian translation of the summary see Supplementary Materials section.
Collapse
Affiliation(s)
- Louella M R Kasbergen
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands.
| | - Erwin de Bruin
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Felicity Chandler
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Louise Sigfrid
- ERGO, Pandemic Sciences Institute, University of Oxford, Oxford, UK; Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford, UK
| | - Xin Hui S Chan
- Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Lauren Hookham
- Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Jia Wei
- Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Siyu Chen
- Nuffield Department of Medicine, University of Oxford, Oxford, UK; High Meadows Environmental Institute, Princeton University, Princeton, NJ, US
| | | | - Sandra Scherbeijn
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Remi N Charrel
- Unite des Virus Emergents, Aix-Marseille Université, Universita di Corsica, IRD 190, Inserm 1207, IRBA, Marseille, France
| | - Nazli Ayhan
- Unite des Virus Emergents, Aix-Marseille Université, Universita di Corsica, IRD 190, Inserm 1207, IRBA, Marseille, France; Centre National de Référence des Arbovirus, Inserm-IRBA, Marseille, France
| | - James L Lee
- ERGO, Pandemic Sciences Institute, University of Oxford, Oxford, UK
| | - Victor M Corman
- Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany; German Center for Infection Research (DZIF), Berlin, Germany
| | - Chantal Reusken
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, RIVML, Bilthoven, Netherlands
| | - Katherine Loens
- Department of Medical Microbiology, University of Antwerp UIA, Antwerp, Belgium
| | - Corneliu Petru Popescu
- Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania
| | - Mihaela Lupse
- Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; The Teaching Hospital for Infectious Diseases, Cluj-Napoca, Romania
| | - Violeta Briciu
- Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; The Teaching Hospital for Infectious Diseases, Cluj-Napoca, Romania
| | - Anca Meda Văsieşiu
- Department of Infectious Diseases, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, Târgu Mureş, Romania
| | - Pellumb Pipero
- Department of Infectious Diseases, Mother Teresa University Hospital Center, Tirana, Albania
| | - Arjan Harxhi
- Faculty of Medicine, Medical University of Tirana, Tirana, Albania
| | - Edmond Puca
- Department of Infectious Diseases, Mother Teresa University Hospital Center, Tirana, Albania
| | | | - Maja Travar
- Department of Microbiology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
| | - Maja Ostojić
- School of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina
| | - Rusmir Baljic
- Unit for Infectious Disease, Clinical Center of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina
| | - Jurica Arapović
- School of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina; Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
| | - Dragan Ledina
- Department of Infectious Diseases, University Hospital Split, Split, Croatia
| | | | - Ivica Čabraja
- Department of Infectious Diseases, Dr Josip Benčević General Hospital, Slavonski Brod, Croatia
| | | | - Stela Halichidis
- Clinical Infectious Diseases Hospital, Constanța, Romania; Faculty of Medicine, Ovidius University, Constanța, Romania
| | - Victoria Birlutiu
- Faculty of Medicine, Lucian Blaga University of Sibiu, Sibiu, Romania; County Clinical Emergency Hospital, Sibiu, Romania
| | - Irina M Dumitru
- Ovidius University of Constanța, Clinical Hospital of Infectious Diseases, Academy of Romanian Scientists, Bucharest, Romania
| | - Ruxandra Moroti
- Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Institute for Infectious Diseases Matei Bals, Bucharest, Romania
| | - Aleksandra Barac
- Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | - Goran Stevanovic
- Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | | | - Vasilios Koulouras
- Intensive Care Unit, University Hospital of Ioannina, University of Ioannina, Ioannina, Greece
| | | | | | - Emmanuel Roilides
- Infectious Diseases Unit, Hippokration General Hospital, Thessaloniki, Greece
| | - Alemka Markotić
- Dr Fran Mihaljević University Hospital for Infectious Diseases, Zagreb, Croatia
| | - Ushma Galal
- Nuffield Department of Primary Care Health Sciences, Clinical Trials Unit, University of Oxford, Oxford, UK
| | - Emmanuelle Denis
- ERGO, Pandemic Sciences Institute, University of Oxford, Oxford, UK
| | - Lynsey Goodwin
- NIHR Health Protection Research Unit for Emerging Zoonotic Infections, University of Liverpool, Liverpool, UK
| | - Lance Turtle
- NIHR Health Protection Research Unit for Emerging Zoonotic Infections, University of Liverpool, Liverpool, UK
| | - Simin Aysel Florescu
- Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania
| | - Hamdi Ramadani
- Clinic of Infectious Diseases, University Clinical Center of Kosovo, Prishtina, Kosovo; Department of Infectious Diseases, University Clinical Centre, Pristina, Kosovo
| | - Herman Goossens
- Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
| | - Margareta Ieven
- Department of Medical Microbiology, University of Antwerp UIA, Antwerp, Belgium; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
| | - Christian Drosten
- Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany
| | - Peter W Horby
- ERGO, Pandemic Sciences Institute, University of Oxford, Oxford, UK
| | - Reina S Sikkema
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Marion P G Koopmans
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | | |
Collapse
Collaborators
Louella M R Kasbergen, Erwin De Bruin, Felicity Chandler, Louise Sigfrid, Xin-Hui S Chan, Lauren Hookham, Jia Wei, Siyu Chen, Corine H GeurtsvanKessel, Sandra Scherbeijn, Remi N Charrel, Nazlı Ayhan, James L Lee, Victor M Corman, Chantal Reusken, Katherine Loens, Corneliu Petru Popescu, Mihaela Lupse, Violeta Briciu, Anca Meda Vasiesiu, Pellumb Pipero, Arjan Harxhi, Edmond Puca, Albina Ponosheci Biçaku, Maja Travar, Maja Ostojić, Rusmir Baljic, Jurica Arapović, Dragan Ledina, Đurđica Cekinović Grbeša, Ivica Čabraja, Ivan-Christian Kurolt, Stela Halichidis, Victoria Birlutiu, Irina M Dumitru, Ruxandra Moroti, Aleksandra Barac, Goran Stevanovic, Athina Pyrpasopoulou, Vasilios Koulouras, Ljiljana Betica Radić, Metaxia N Papanikolaou, Ioannis Andrianopoulos, Catalin Apostolescu, Silvia Bino, Maria Chondrogiorgi, Natalie Cleton, Daniel Codreanu, Tomasović Domagoj, Edita Dražić Maras, Mario Duvnjak, Adriana Hristea, Raluca M Hrisca, Kevin Jacobs, Ilias Iosifidis, Puškarić Ivana, Alma Gabriela Kosa, Iris Koshovari, Mandy Kuijstermans, Arsim Kurti, Santini Marija, Iosif Marincu, Julia Melchert, Pieter Moons, Visnja Mrdjen, Cristian M Niculae, Nenad Pandak, Lul Raka, Iordanis Romiopoulos, Željana Sulaver, Gratiela Tardei, Nijaz Tihic, Skuhala Tomislava, Antonija Verhaz, Mihaela Zaharia, Mačak Šafranko Željka, Ivana Vrkic, Ankica Vujovic, Emmanuel Roilides, Alemka Markotić, Ushma Galal, Emmanuelle Denis, Lynsey Goodwin, Lance Turtle, Simin Aysel Florescu, Hamdi Ramadani, Herman Goossens, Margareta Ieven, Christian Drosten, Peter W Horby, Reina S Sikkema, Marion P G Koopmans,
Collapse
|
3
|
Romani FE, Luvira V, Chancharoenthana W, Albanese M, Maddaloni L, Branda F, D'Amelio S, Gabrielli S, Scagnolari C, Mastroianni CM, Ceccarelli G, d'Ettorre G. Human microbiota in dengue infection: A narrative review. Microb Pathog 2025; 205:107643. [PMID: 40306589 DOI: 10.1016/j.micpath.2025.107643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2024] [Revised: 04/24/2025] [Accepted: 04/28/2025] [Indexed: 05/02/2025]
Abstract
Dengue fever, a widespread mosquito-borne viral infection in tropical regions, typically manifests fever and gastrointestinal symptoms, including nausea, vomiting, and diarrhea. However, the human gut microbiota's role in dengue pathogenesis remains incompletely understood. Studies have demonstrated dysbiosis during dengue virus infection, characterized by increased abundance of potentially pathogenic bacteria like Bacteroidaceae and Proteobacteria, particularly during the critical phase. Furthermore, microbial translocation and leaky gut syndrome, characterized by the translocation of intestinal microbial products, have been observed in dengue patients and are associated with hypercytokinemia, plasma leakage, and disease severity. These findings underscore the necessity for an in-depth investigation into the role of human intestinal microbiota as a potential contributing factor in the pathogenesis and progression of dengue. Further research focusing on human intestinal microbiota, leaky gut syndrome, and the potential implications of treatment with oral bacteriotherapy, as previously observed in other viral diseases, is essential to clarify dengue pathology and evaluate new therapeutic strategies.
Collapse
Affiliation(s)
- Francesco Eugenio Romani
- Department of Public Health and Infectious Diseases, University of Rome Sapienza, Rome, Italy; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand
| | - Viravarn Luvira
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand
| | - Wiwat Chancharoenthana
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand
| | - Mattia Albanese
- Department of Public Health and Infectious Diseases, University of Rome Sapienza, Rome, Italy; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand
| | - Luca Maddaloni
- Department of Public Health and Infectious Diseases, University of Rome Sapienza, Rome, Italy
| | - Francesco Branda
- Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, 00128, Rome, Italy
| | - Stefano D'Amelio
- Department of Public Health and Infectious Diseases, University of Rome Sapienza, Rome, Italy
| | - Simona Gabrielli
- Department of Public Health and Infectious Diseases, University of Rome Sapienza, Rome, Italy
| | - Carolina Scagnolari
- Department of Molecular Medicine, Laboratory of Virology, University of Rome Sapienza, Rome, Italy
| | | | - Giancarlo Ceccarelli
- Department of Public Health and Infectious Diseases, University of Rome Sapienza, Rome, Italy; Azienda Ospedaliero Universitaria Policlinico Umberto I, Rome, Italy; Migrant and Global Health Research Organization (Mi-HeRO), Rome, Italy.
| | - Gabriella d'Ettorre
- Department of Public Health and Infectious Diseases, University of Rome Sapienza, Rome, Italy
| |
Collapse
|
4
|
Sigfrid L, Chan XHS, Kasbergen LMR, Hookham L, Wei J, Chen S, Lee JL, Sikkema RS, de Bruin E, Corman VM, Reusken C, Loens K, Popescu CP, Lupse M, Briciu V, Pipero P, Harxhi A, Puca E, Ponosheci Biçaku A, Travar M, Ostojic M, Baljic R, Arapović J, Ledina D, Cekinović Grbeša Đ, Čabraja I, Văsieşiu AM, Kurolt IC, Halichidis S, Birlutiu V, Sulaver Z, Dumitru IM, Moroti R, Barac A, Stevanovic G, Pyrpasopoulou A, Papanikolaou MN, Koulouras V, Betica Radić L, Roilides E, Markotić A, Galal U, Denis E, Goodwin L, Turtle L, Marincu I, Florescu SA, Ramadani H, Charrel RN, Goossens H, Ieven M, Drosten C, Horby PW, Koopmans MPG. Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study. THE LANCET. INFECTIOUS DISEASES 2025:S1473-3099(24)00655-8. [PMID: 39987929 DOI: 10.1016/s1473-3099(24)00655-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/18/2024] [Revised: 09/10/2024] [Accepted: 09/24/2024] [Indexed: 02/25/2025]
Abstract
BACKGROUND Arboviruses have expanded into new regions in Europe, yet data indicate gaps in disease notifications and a risk of further spread. We aimed to report on prevalence, clinical management, and outcomes of endemic arbovirus infections in southeast Europe. METHODS In this prospective observational study (MERMAIDS-ARBO), we enrolled adults (age ≥18 years) hospitalised with an arbovirus-compatible disease syndrome within 21 days of symptom onset across 21 hospitals in seven countries in southeast Europe over four arbovirus seasons (May 1-Oct 31, during 2016-19). We obtained data from case report forms completed by site investigators on admission and discharge. Participants were excluded if they had non-infectious CNS disorders, symptoms of another confirmed cause, an identified focal source of infection, or symptoms caused by recurrence of a pre-existing condition. The primary outcome was the proportion of participants with confirmed or probable acute infections with West Nile virus (WNV), tick-borne encephalitis virus (TBEV), Crimean-Congo haemorrhagic fever virus (CCHFV), or Toscana virus (TOSV), per reference laboratory criteria. Secondary outcomes were the proportions of patients treated with antivirals, antibiotics, or corticosteroids; the proportion of patients requiring intensive care; hospital length of stay; and mortality. FINDINGS Of 2896 adults screened for eligibility, 929 were recruited and 913 met protocol-defined eligibility criteria (median age 43·1 years [IQR 29·5-59·7]; 550 [60%] men, 361 [40%] women, and two [<1%] with missing data). 530 (58%) participants presented with suspected meningitis, encephalitis, or both, and 318 (35%) with fever plus myalgia, fever plus arthralgia, or both. 820 (90%) reported no international travel within 21 days before symptom onset. 727 (80%) were administered antibiotics, 379 (42%) corticosteroids, and 222 (24%) antivirals. The median length of hospital stay was 9 days (IQR 6-14), and 113 (12%) required intensive care. Of 847 participants with a reference laboratory sample who met full eligibility criteria for analysis, 110 (13%) were diagnosed with 114 confirmed or probable acute arbovirus infections (four had coinfections or cross-reactivity): one (<1%) with CCHFV, 16 (2%) with TBEV, 44 (5%) with TOSV, and 53 (6%) with WNV. There was one death (<1%) of an individual with WNV. Of the 110 participants, 49 (45%) had a local clinician-attributed arbovirus discharge diagnosis. INTERPRETATION Our data highlight the need to strengthen arbovirus surveillance systems for the early detection of emerging and re-emerging outbreaks, including investments to increase awareness of arbovirus infections among clinicians, to improve access to specialist diagnostics, and to develop effective and accessible vaccines and treatments to protect populations and health systems in southeast Europe. FUNDING European Commission and Versatile Emerging infectious disease Observatory. TRANSLATIONS For the Greek, Albanian, Romanian, Bosnian, Serbian, and Croatian translation of the summary see Supplementary Materials section.
Collapse
Affiliation(s)
- Louise Sigfrid
- ERGO, Pandemic Sciences Institute, University of Oxford, Oxford, UK; Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford, UK.
| | - Xin Hui S Chan
- Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Louella M R Kasbergen
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Lauren Hookham
- Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Jia Wei
- Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Siyu Chen
- Nuffield Department of Medicine, University of Oxford, Oxford, UK; High Meadows Environmental Institute, Princeton University, Princeton, NJ, USA
| | - James L Lee
- ERGO, Pandemic Sciences Institute, University of Oxford, Oxford, UK
| | - Reina S Sikkema
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Erwin de Bruin
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Victor M Corman
- Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany; German Center for Infection Research (DZIF), Berlin, Germany
| | - Chantal Reusken
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, RIVML, Bilthoven, Netherlands
| | - Katherine Loens
- Department of Medical Microbiology, University of Antwerp UIA, Antwerp, Belgium
| | - Corneliu Petru Popescu
- Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania
| | - Mihaela Lupse
- Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; The Teaching Hospital for Infectious Diseases, Cluj-Napoca, Romania
| | - Violeta Briciu
- Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; The Teaching Hospital for Infectious Diseases, Cluj-Napoca, Romania
| | - Pellumb Pipero
- Department of Infectious Diseases, Mother Teresa University Hospital Center, Tirana, Albania
| | - Arjan Harxhi
- Faculty of Medicine, Medical University of Tirana, Tirana, Albania
| | - Edmond Puca
- Department of Infectious Diseases, Mother Teresa University Hospital Center, Tirana, Albania
| | | | - Maja Travar
- Department of Microbiology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
| | - Maja Ostojic
- School of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina
| | - Rusmir Baljic
- Unit for Infectious Disease, Clinical Center of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina
| | - Jurica Arapović
- School of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina; Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
| | - Dragan Ledina
- Department of Infectious Diseases, University Hospital Split, Split, Croatia
| | | | - Ivica Čabraja
- Department of Infectious Diseases, Dr Josip Benčević General Hospital, Slavonski Brod, Croatia
| | - Anca Meda Văsieşiu
- Department of Infectious Diseases, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, Târgu Mureş, Romania
| | | | - Stela Halichidis
- Clinical Infectious Diseases Hospital, Constanța, Romania; Faculty of Medicine, Ovidius University, Constanța, Romania
| | - Victoria Birlutiu
- Faculty of Medicine, Lucian Blaga University of Sibiu, Sibiu, Romania; County Clinical Emergency Hospital, Sibiu, Romania
| | - Zeljana Sulaver
- Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
| | - Irina M Dumitru
- Ovidius University of Constanța, Clinical Hospital of Infectious Diseases, Academy of Romanian Scientists, Bucharest, Romania
| | - Ruxandra Moroti
- Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Institute for Infectious Diseases Matei Bals, Bucharest, Romania
| | - Aleksandra Barac
- Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | - Goran Stevanovic
- Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | | | - Metaxia N Papanikolaou
- Intensive Care Unit, University Hospital of Ioannina, University of Ioannina, Ioannina, Greece
| | - Vasilios Koulouras
- Intensive Care Unit, University Hospital of Ioannina, University of Ioannina, Ioannina, Greece; University Hospital of Ioannina, Ioannina, Greece
| | | | - Emmanuel Roilides
- Infectious Diseases Unit, Hippokration General Hospital, Thessaloniki, Greece
| | - Alemka Markotić
- Dr Fran Mihaljević University Hospital for Infectious Diseases, Zagreb, Croatia
| | - Ushma Galal
- Nuffield Department of Primary Care Health Sciences, Clinical Trials Unit, University of Oxford, Oxford, UK
| | - Emmanuelle Denis
- ERGO, Pandemic Sciences Institute, University of Oxford, Oxford, UK
| | - Lynsey Goodwin
- NIHR Health Protection Research Unit for Emerging Zoonotic Infections, University of Liverpool, Liverpool, UK
| | - Lance Turtle
- NIHR Health Protection Research Unit for Emerging Zoonotic Infections, University of Liverpool, Liverpool, UK
| | - Iosif Marincu
- Victor Babes University of Medicine and Pharmacy of Timisoara, Timisoara, Romania
| | - Simin Aysel Florescu
- Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania
| | - Hamdi Ramadani
- Clinic of Infectious diseases, University Clinical Center of Kosovo, Prishtina, Kosovo
| | - Remi N Charrel
- Unite des Virus Emergents, Aix-Marseille Université, Universita di Corsica, IRD 190, Inserm 1207, IRBA, Marseille, France
| | - Herman Goossens
- Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
| | - Margareta Ieven
- Department of Medical Microbiology, University of Antwerp UIA, Antwerp, Belgium; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
| | - Christian Drosten
- Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany
| | - Peter W Horby
- ERGO, Pandemic Sciences Institute, University of Oxford, Oxford, UK
| | - Marion P G Koopmans
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| |
Collapse
|
5
|
Presser LD, Baronti C, Moegling R, Pezzi L, Lustig Y, Gossner CM, Reusken CBEM, Charrel RN, on behalf of EVD-LabNet. Excellent capability for molecular detection of Aedes-borne dengue, Zika, and chikungunya viruses but with a need for increased capacity for yellow fever and Japanese encephalitis viruses: an external quality assessment in 36 European laboratories. J Clin Microbiol 2025; 63:e0091024. [PMID: 39679671 PMCID: PMC11784407 DOI: 10.1128/jcm.00910-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2024] [Accepted: 10/24/2024] [Indexed: 12/17/2024] Open
Abstract
Mosquito-borne viruses represent a large global health burden. With geographic expansion of competent vectors for chikungunya virus (CHIKV), dengue virus (DENV), and Zika virus (ZIKV) in Europe, it is anticipated that the number of autochthonous cases of these tropical viruses in Europe will increase. Therefore, regular assessment of diagnostic capabilities in Europe is important. Our aim was to evaluate the mosquito-borne virus molecular detection capability of expert European laboratories by conducting an external quality assessment in October 2023. Molecular panels included 12 plasma samples: one alphavirus (CHIKV), four orthoflaviviruses (ZIKV, yellow fever virus [YFV], DENV, and Japanese encephalitis virus [JEV]), and two negative control samples. Mosquito-borne virus detection was assessed among 36 laboratories in 24 European countries. Adequate capabilities were lacking for YFV and JEV. Many laboratories relied on a mix of laboratory-developed tests (some of which were pan-orthoflavivirus or pan-alphavirus in combination with sequencing) and commercial assays. 47.2% of laboratories characterized all external quality assessment (EQA) samples correctly. Correct result rates were 100% for CHIKV and ZIKV and >99% for DENV, but laboratories lacked capacity, specificity, and sensitivity for JEV and YFV. Three of the viruses in this panel emerged and transiently circulated in Europe: CHIKV, ZIKV, and DENV. Molecular detection was excellent for those viruses, but <50% is accurate for the remainder of the panel. With the possibility or continuation of imported cases and a growing global concern about climate change and vector expansion, progress toward rapid, accurate mosquito-borne virus diagnostics in Europe is recommended, as well as regular EQAs to monitor it.IMPORTANCEThe external quality assessment (EQA) focused on Aedes-borne viruses: chikungunya virus (CHIKV), dengue virus (DENV), Zika virus (ZIKV), and yellow fever virus (YFV). Japanese encephalitis virus, an orthoflavivirus that is spread by mosquito species belonging to the genus Culex, was included in the quality assessment as well. CHIKV, DENV, and ZIKV have proven potential for transient and limited circulation in Europe upon introduction of viremic travelers returning to Aedes albopictus-endemic regions. Results of this EQA were excellent for those viruses, but <50% is accurate for the remainder of the panel (YFV and Japanese encephalitis virus). Considering imported cases and the threat of climate change and competent vector expansion, progress toward rapid, accurate mosquito-borne virus diagnostics in Europe is recommended.
Collapse
Affiliation(s)
- Lance D. Presser
- National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control, Bilthoven, the Netherlands
| | - Cécile Baronti
- Unite des Virus Emergents (UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm 1207, IRBA), Marseille, France
| | - Ramona Moegling
- National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control, Bilthoven, the Netherlands
| | - Laura Pezzi
- Unite des Virus Emergents (UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm 1207, IRBA), Marseille, France
- National Reference Center for Arboviruses, Inserm-IRBA, Marseille, France
| | - Yaniv Lustig
- Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Center, Ramat-Gan, Israel
| | - Céline M. Gossner
- Disease Programme Unit, European Centre for Disease Prevention and Control, Solna, Sweden
| | - Chantal B. E. M. Reusken
- National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control, Bilthoven, the Netherlands
| | - Rémi N. Charrel
- Unite des Virus Emergents (UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm 1207, IRBA), Marseille, France
- Laboratoire des Infections Virales Aigues et Tropicales, AP-HM Hôpitaux Universitaires de Marseille, Marseille, France
| | - on behalf of EVD-LabNet
- National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control, Bilthoven, the Netherlands
- Unite des Virus Emergents (UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm 1207, IRBA), Marseille, France
- National Reference Center for Arboviruses, Inserm-IRBA, Marseille, France
- Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Center, Ramat-Gan, Israel
- Disease Programme Unit, European Centre for Disease Prevention and Control, Solna, Sweden
- Laboratoire des Infections Virales Aigues et Tropicales, AP-HM Hôpitaux Universitaires de Marseille, Marseille, France
| |
Collapse
|
6
|
Heyrani A, Pourjalil F, Hosseini Z, Shahabi N, Asadipour E. A comprehensive scoping review of global educational strategies and outcomes in aedes-borne disease control. Arch Public Health 2024; 82:176. [PMID: 39380105 PMCID: PMC11459706 DOI: 10.1186/s13690-024-01412-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2024] [Accepted: 09/30/2024] [Indexed: 10/10/2024] Open
Abstract
BACKGROUND Aedes mosquito is the primary vector of emerging or re-emerging arboviruses that threaten public health worldwide. Many efforts have been made to develop interventions to control the Aedes mosquito. This scoping review was conducted to identify the nature and scope of educational interventions to prevent and control diseases transmitted through the Aedes mosquito. The findings can be used to evaluate, compare, and develop appropriate control strategies. METHODS The present scoping review was conducted in 2023 and used Arksey and O'Malley's approach, which involves five key stages. To search for academic papers, PubMed, Web of Science, Scopus and ScienceDirect databases were used with a combination of keywords about Aedes mosquitoes, educational interventions, and disease prevention and control. The search was not limited by the publication date, yet only included studies published in English. Studies were included that reported the educational interventions about Aedes mosquito control at the community or organizational level. The screening of papers was done based on the PRISMA-ScR guideline. Excel 2019 was used for data analysis. RESULTS Initially, 3,172 papers were extracted, and after screenings and reviews, a total number of 45 final papers were selected. The studies focused on educational interventions. Twenty interventional studies were at the organizational level and 25 at the community level. The latter was the most commonly used strategy. Interventions using educational approaches have achieved sustainable results. Out of the forty-five studies, twenty-one were assessed to have a low risk of bias. CONCLUSIONS The present scoping review evaluates the effectiveness of educational interventions at various community levels for controlling Aedes-borne diseases, emphasizing the need for multidisciplinary collaboration. Controlling Aedes mosquitoes using education and attracting the community's participation is an effective approach to reduce diseases transmitted through Aedes. The development of education at different levels of the community, such as educational and occupational environments, can play a role in the effectiveness of societal education and can be more cost-effective. Maintaining the effect of this approach is challenging because it requires multi-sector and multidisciplinary team participation and active community engagement over the long term. Further research is required to explore the removal of barriers to the implementation of educational interventions and the consistency of effects.
Collapse
Affiliation(s)
- Ali Heyrani
- Social Determinants in Health Promotion Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
| | - Farzaneh Pourjalil
- Student Research Committee, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
| | - Zahra Hosseini
- Social Determinants in Health Promotion Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
| | - Nahid Shahabi
- Social Determinants in Health Promotion Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
| | - Elaheh Asadipour
- Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of medical sciences, Kerman, Iran
| |
Collapse
|
7
|
Shanshin DV, Borisevich SS, Shaprova ON, Nesmeyanova VS, Bondar AA, Porozov YB, Khamitov EM, Kolosova EA, Shelemba AA, Ushkalenko ND, Protopopova EV, Sergeev AA, Loktev VB, Shcherbakov DN. Phage Display Revealed the Complex Structure of the Epitope of the Monoclonal Antibody 10H10. Int J Mol Sci 2024; 25:10311. [PMID: 39408641 PMCID: PMC11476565 DOI: 10.3390/ijms251910311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2024] [Revised: 09/03/2024] [Accepted: 09/06/2024] [Indexed: 10/20/2024] Open
Abstract
The annual number of reported human cases of flavivirus infections continues to increase. Measures taken by local healthcare systems and international organizations are not fully successful. In this regard, new approaches to treatment and prevention of flavivirus infections are relevant. One promising approach is to use monoclonal antibody preparations. The mouse mAb 10H10 is capable of interacting with viruses belonging to the genus Orthoflavivirus which are pathogenic to humans. ELISA and molecular modeling data can indicate that mAb 10H10 recognizes the fusion loop region of E protein. The KD of interaction between the mAb 10H10 and recombinant analogs of the E protein of the tick-borne encephalitis (TBEV), Zika (ZIKV) and dengue (DENV) viruses range from 1.5 to 4 nM. The aim of this study was to map the epitope of this antibody using phage display technology. After three rounds of biopanning, 60 individual phage clones were chosen. The amino acid sequences of the selected peptides were conveniently divided into five groups. Based on the selected peptides, bacteriophages were obtained carrying peptides on the surfaces of the pIII and pVIII proteins, which were tested for binding to the antibody in ELISA. Thus, the epitope of the mAb 10H10 is the highly conserved region 98-DRGWGNXXGLFGK-110 of the flavivirus E protein. The structures of the complexes of the identified peptides with the antibody paratope are proposed using the molecular docking and dynamics methods.
Collapse
Affiliation(s)
- Daniil V. Shanshin
- State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, Koltsovo 630559, Russia; (D.N.S.); (O.N.S.); (V.S.N.); (E.A.K.); (N.D.U.); (E.V.P.); (A.A.S.); (V.B.L.)
| | - Sophia S. Borisevich
- Laboratory of Physical and Chemical Methods of Analysis, Ufa Institute of Chemistry UFRS RAS, Ufa 450054, Russia;
- Synchrotron Radiation Facility—Siberian Circular Photon Source “SKlF” Boreskov Institute of Catalysis of Siberian Branch of the Russian Academy of Sciences, Koltsovo 630559, Russia
| | - Olga N. Shaprova
- State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, Koltsovo 630559, Russia; (D.N.S.); (O.N.S.); (V.S.N.); (E.A.K.); (N.D.U.); (E.V.P.); (A.A.S.); (V.B.L.)
- Research Institute of Biological Medicine Center for Recombinant Technologies, Altay State University, Barnaul 656049, Russia
| | - Valentina S. Nesmeyanova
- State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, Koltsovo 630559, Russia; (D.N.S.); (O.N.S.); (V.S.N.); (E.A.K.); (N.D.U.); (E.V.P.); (A.A.S.); (V.B.L.)
| | - Alexander A. Bondar
- Genomics Core Facility, Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk 630090, Russia;
| | - Yuri B. Porozov
- Laboratory of Angiopathology, The Institute of General Pathology and Pathophysiology, 8 Baltiyskaya Street, Moscow 125315, Russia;
- Advitam Laboratory, 11108 Belgrade, Serbia
| | - Edward M. Khamitov
- Laboratory of Physical and Chemical Methods of Analysis, Ufa Institute of Chemistry UFRS RAS, Ufa 450054, Russia;
| | - Evgeniia A. Kolosova
- State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, Koltsovo 630559, Russia; (D.N.S.); (O.N.S.); (V.S.N.); (E.A.K.); (N.D.U.); (E.V.P.); (A.A.S.); (V.B.L.)
- Research Institute of Biological Medicine Center for Recombinant Technologies, Altay State University, Barnaul 656049, Russia
| | - Arseniya A. Shelemba
- Federal State Budgetary Scientific Institution “Federal Research Center for Fundamental and Translational Medicine”, Novosibirsk 630117, Russia;
| | - Nikita D. Ushkalenko
- State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, Koltsovo 630559, Russia; (D.N.S.); (O.N.S.); (V.S.N.); (E.A.K.); (N.D.U.); (E.V.P.); (A.A.S.); (V.B.L.)
| | - Elena V. Protopopova
- State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, Koltsovo 630559, Russia; (D.N.S.); (O.N.S.); (V.S.N.); (E.A.K.); (N.D.U.); (E.V.P.); (A.A.S.); (V.B.L.)
| | - Artemiy A. Sergeev
- State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, Koltsovo 630559, Russia; (D.N.S.); (O.N.S.); (V.S.N.); (E.A.K.); (N.D.U.); (E.V.P.); (A.A.S.); (V.B.L.)
| | - Valery B. Loktev
- State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, Koltsovo 630559, Russia; (D.N.S.); (O.N.S.); (V.S.N.); (E.A.K.); (N.D.U.); (E.V.P.); (A.A.S.); (V.B.L.)
| | - Dmitriy N. Shcherbakov
- State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, Koltsovo 630559, Russia; (D.N.S.); (O.N.S.); (V.S.N.); (E.A.K.); (N.D.U.); (E.V.P.); (A.A.S.); (V.B.L.)
- Research Institute of Biological Medicine Center for Recombinant Technologies, Altay State University, Barnaul 656049, Russia
| |
Collapse
|
8
|
Zawadzka M, Lis A, Marszałkowska-Jakubik J, Szymański P. Evaluation of Soldiers' Knowledge and Sense of Threats Regarding Exposure to Biological Risk Factors at the Place of Service. Healthcare (Basel) 2024; 12:1777. [PMID: 39273800 PMCID: PMC11394985 DOI: 10.3390/healthcare12171777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2024] [Revised: 08/24/2024] [Accepted: 08/30/2024] [Indexed: 09/15/2024] Open
Abstract
Exposure to harmful biological agents and the level of knowledge about specific risk factors are extremely important topics, especially among military personnel. This study evaluates the knowledge and perceptions of soldiers regarding exposure to biological risk factors during their service. This research was conducted using an online survey distributed through the WBBS research panel, in which 1331 soldiers from various demographic groups and ranks participated. The survey assessed awareness of biological threats, the level of knowledge about preventive measures, and the perceived adequacy of occupational health and safety training. The findings reveal that over 80% of respondents possess some level of knowledge about the types of biological agents they may encounter, yet significant gaps remain, particularly in training related to region-specific infectious diseases, with more than 75% of participants having not received such training. Additionally, approximately 5% of respondents reported high exposure, and around 4% reported very high exposure to harmful biological agents, highlighting the need for enhanced educational programs and preventive measures in military contexts. The study underscores the importance of continuous education and training to mitigate risks associated with biological hazards in military environments.
Collapse
Affiliation(s)
- Magdalena Zawadzka
- Department of Epidemiology and Public Health, Medical University of Lodz, Żeligowskiego 7/9, 90-752 Lodz, Poland
- Department of Organization of the Health Care System, Prevention and Treatment Team, Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland
| | - Aleksandra Lis
- Department of Pharmaceutical Chemistry, Drug Analyses and Radiopharmacy, Medical University of Lodz, Muszyńskiego 1, 90-151 Łódź, Poland
| | - Justyna Marszałkowska-Jakubik
- Department of Organization of the Health Care System, Prevention and Treatment Team, Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland
| | - Paweł Szymański
- Department of Pharmaceutical Chemistry, Drug Analyses and Radiopharmacy, Medical University of Lodz, Muszyńskiego 1, 90-151 Łódź, Poland
- Department of Radiobiology and Radiation Protection, Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland
| |
Collapse
|
9
|
Megenas JA, Dadi ML, Mekonnen TK, Larrick JW, Kassa GM. Seroprevalence and Co-Circulation of Rift Valley Fever Virus and West Nile Fever Virus in Livestock Population of Afar Region, Northeast Ethiopia. Vet Med Int 2024; 2024:8249077. [PMID: 39224542 PMCID: PMC11368548 DOI: 10.1155/2024/8249077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2024] [Revised: 07/23/2024] [Accepted: 08/05/2024] [Indexed: 09/04/2024] Open
Abstract
The distribution, epidemiology, and socioeconomic impact of Rift Valley fever (RVF) and West Nile (WN) viruses are poorly known in areas of sub-Saharan countries like Ethiopian pastoral region. The human and livestock density in the area has increased greatly in recent years, but little work has been done on arboviral diseases and their potential impact on human and livestock health. The aim of this study was to detect the circulation of zoonotic arboviruses such as Rift Valley fever virus and West Nile viruses in the livestock population and to estimate seroprevalence in Afar pastoral area northeast Ethiopia. Cross-sectional serological survey was carried out in 736 serum samples from which cattle (224), camel (155), goats (121), sheep (144), and donkeys (92) were tested for the presence of anti-RVFV and anti-WNV IgG using a competitive enzyme-linked immunosorbent assay (c-ELISA) in two purposively selected districts of the Afar region. The present study revealed a 9.1% (95% CI = 8.86-9.29) seroprevalence of co-circulation of RVF and WNV. High 32/155 (20.7%) seroprevalence of co-circulation was seen in camels, followed by goat 14/121 (11.6%), cattle 16/224 (7.14%), and sheep 5/144 (3.5%), respectively, and higher 41/421 (9.7%) seroprevalence of co-circulation was observed in Amibara district than Haruka district. Camels were seven times (OR: 7.016, 95% CI = 2.639-18.653) more likely to be seropositive for the co-circulation than sheep (p ≤ 0.001). Livestock herds found in Amibara district were 1.2 times (OR: 1.165, 95% CI = 0.680-1.996) more likely to be seropositive for RVFV infection than those in Haruka areas. Given the co-occurrence of RVFV and WNV circulations, along with often suboptimal human and animal health surveillance in many similar areas' attention should be given. Investigation of the potential socioeconomic and health impacts of zoonotic arbovirus infections in such areas is crucial. Since both RVFV and WNFV are transmitted through a mosquito vector, avoiding mosquito bites is the primary method of prevention.
Collapse
Affiliation(s)
- Jemberu Alemu Megenas
- Department of Veterinary MicrobiologyImmunology and Public HealthCollege of Veterinary MedicineAddis Ababa University, Bishoftu, Ethiopia
- College of Agriculture and Natural ResourcesGambella University, Gambella, Ethiopia
| | | | - Tesfu Kassa Mekonnen
- Aklilu Lemma Institute of PathobiologyAddis Ababa University, Addis Ababa, Ethiopia
| | | | - Gezahegne Mamo Kassa
- Department of Veterinary MicrobiologyImmunology and Public HealthCollege of Veterinary MedicineAddis Ababa University, Bishoftu, Ethiopia
| |
Collapse
|
10
|
Ergönül Ö, Keske Ş, Ksinzik A, Güldan M, Özbek L, Azap A, Şimşek-Yavuz S, Can F, Sakarya S. The challenges in the monitoring of infectious diseases after the earthquake in Türkiye in 2023. THE LANCET. INFECTIOUS DISEASES 2023; 23:e482-e488. [PMID: 37419128 DOI: 10.1016/s1473-3099(23)00362-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Revised: 05/24/2023] [Accepted: 05/25/2023] [Indexed: 07/09/2023]
Abstract
After the devastating earthquake in Türkiye and Syria in February, 2023, the long-term failure to meet the need for shelter, unfavourable living conditions in tent settlements, poor access to clean drinking water, water suitable for personal hygiene, and sanitary facilities, as well as interruptions in provision of primary health-care services, have emerged as the most important risk factors contributing to the spread of infectious diseases. 3 months after the earthquake, most of these problems persist in Türkiye. Data on the control of infectious diseases are scarce according to the reports prepared by medical specialist associations based on observations of health-care providers working in the region and statements made by the local health authorities. According to these unsystematised data, and considering the conditions in the region, faecal-oral transmissible gastrointestinal infections, as well as respiratory and vector-borne infections, are the main challenges. Vaccine-preventable diseases, such as measles, varicella, meningitis, and polio can be spread in temporary shelters due to interrupted vaccine services and crowded living conditions. In addition to controlling risk factors for infectious diseases, sharing data on the status and control of infectious diseases in the region with the community, health-care providers, and relevant expert groups should be a priority to improve the understanding of the effects of interventions and prepare for possible infectious disease outbreaks.
Collapse
Affiliation(s)
- Önder Ergönül
- Koç University İşbank Center for Infectious Diseases (KUISCID), Istanbul, Türkiye; Department of Infectious Diseases and Clinical Microbiology, Koç University School of Medicine, Istanbul, Türkiye.
| | - Şiran Keske
- Koç University İşbank Center for Infectious Diseases (KUISCID), Istanbul, Türkiye; Department of Infectious Diseases and Clinical Microbiology, Koç University School of Medicine, Istanbul, Türkiye
| | - Apolina Ksinzik
- Department of Infectious Diseases and Clinical Microbiology, Koç University School of Medicine, Istanbul, Türkiye; Heidelberg University, Medical Faculty Mannheim, Mannheim, Germany
| | - Mustafa Güldan
- Department of Infectious Diseases and Clinical Microbiology, Koç University School of Medicine, Istanbul, Türkiye
| | - Laşin Özbek
- Department of Infectious Diseases and Clinical Microbiology, Koç University School of Medicine, Istanbul, Türkiye
| | - Alpay Azap
- Department of Infectious Diseases and Clinical Microbiology, Ankara University Medical Faculty, Ankara, Türkiye
| | - Serap Şimşek-Yavuz
- Department of Infectious Diseases and Clinical Microbiology, Istanbul University Medical Faculty, Istanbul, Türkiye
| | - Füsun Can
- Koç University İşbank Center for Infectious Diseases (KUISCID), Istanbul, Türkiye; Department of Medical Microbiology, Koç University School of Medicine, Istanbul, Türkiye
| | - Sibel Sakarya
- Koç University İşbank Center for Infectious Diseases (KUISCID), Istanbul, Türkiye; Department of Public Health, Koç University School of Medicine, Istanbul, Türkiye
| |
Collapse
|
11
|
Nicoletto G, Richter SN, Frasson I. Presence, Location and Conservation of Putative G-Quadruplex Forming Sequences in Arboviruses Infecting Humans. Int J Mol Sci 2023; 24:ijms24119523. [PMID: 37298474 DOI: 10.3390/ijms24119523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 05/12/2023] [Accepted: 05/12/2023] [Indexed: 06/12/2023] Open
Abstract
Guanine quadruplexes (G4s) are non-canonical nucleic acid structures formed by guanine (G)-rich tracts that assemble into a core of stacked planar tetrads. G4s are found in the human genome and in the genomes of human pathogens, where they are involved in the regulation of gene expression and genome replication. G4s have been proposed as novel pharmacological targets in humans and their exploitation for antiviral therapy is an emerging research topic. Here, we report on the presence, conservation and localization of putative G4-forming sequences (PQSs) in human arboviruses. The prediction of PQSs was performed on more than twelve thousand viral genomes, belonging to forty different arboviruses that infect humans, and revealed that the abundance of PQSs in arboviruses is not related to the genomic GC content, but depends on the type of nucleic acid that constitutes the viral genome. Positive-strand ssRNA arboviruses, especially Flaviviruses, are significantly enriched in highly conserved PQSs, located in coding sequences (CDSs) or untranslated regions (UTRs). In contrast, negative-strand ssRNA and dsRNA arboviruses contain few conserved PQSs. Our analyses also revealed the presence of bulged PQSs, accounting for 17-26% of the total predicted PQSs. The data presented highlight the presence of highly conserved PQS in human arboviruses and present non-canonical nucleic acid-structures as promising therapeutic targets in arbovirus infections.
Collapse
Affiliation(s)
- Giulia Nicoletto
- Department of Molecular Medicine, University of Padua, Via A. Gabelli 63, 35121 Padua, Italy
| | - Sara N Richter
- Department of Molecular Medicine, University of Padua, Via A. Gabelli 63, 35121 Padua, Italy
| | - Ilaria Frasson
- Department of Molecular Medicine, University of Padua, Via A. Gabelli 63, 35121 Padua, Italy
| |
Collapse
|
12
|
Camprubí-Ferrer D, Oteo JA, Bottieau E, Genton B, Balerdi-Sarasola L, Portillo A, Cobuccio L, Van Den Broucke S, Santibáñez S, Cadar D, Rodriguez-Valero N, Almuedo-Riera A, Subirà C, d'Acremont V, Martinez MJ, Roldán M, Navero-Castillejos J, Van Esbroeck M, Muñoz J. Doxycycline responding illnesses in returning travellers with undifferentiated non-malaria fever: a European multicentre prospective cohort study. J Travel Med 2023; 30:6657742. [PMID: 35932455 DOI: 10.1093/jtm/taac094] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Revised: 06/11/2022] [Accepted: 06/29/2022] [Indexed: 11/15/2022]
Abstract
BACKGROUND Diagnosis of undifferentiated non-malaria fevers (NMF) in returning travellers is a great challenge. Currently, there is no consensus about the use of empirical antibiotics in returning travellers with undifferentiated NMF. Although studies in endemic areas showed that a wide range of pathogens implicated in undifferentiated NMF are treatable with doxycycline, the role of doxycycline in returning travellers with fever still has to be explored. METHODS Prospective European multicentre cohort study of febrile international travellers (November 2017-November 2019). Immunological and molecular diagnostic techniques for doxycycline responding illnesses (DRI) agents such as Anaplasma phagocytophilum, spotted fever group Rickettsia spp., typhus group Rickettsia spp., Coxiella burnetii, Bartonella spp., Orientia tsutsugamushi, Borrelia miyamotoi, Borrelia recurrentis and Leptospira spp. were systematically performed in all patients with undifferentiated NMF. We estimated the prevalence and predictive factors of DRI in returning travellers with undifferentiated NMF. RESULTS Among 347 travellers with undifferentiated NMF, 106 (30·5%) were finally diagnosed with DRI. Only 57 (53·8%) of the 106 DRI infections were diagnosed by the standard of care. The main causes of DRI were: 55 (51·9%) Rickettsia spp., 16 (15·1%) C. burnetii; 15 (14·2%) Bartonella spp.; 13 (12·3%) Leptospira spp. and 10 (9·5%) A. phagocytophilum. The only predictive factor associated with DRI was presenting an eschar (aOR 39·52, 95%CI 4·85-322·18). Features of dengue such as retro-orbital pain (aOR 0·40, 95%CI 0·21-0·76) and neutropenia (aOR 0·41, 95%CI 0·21-0·79) were negatively associated with DRI. CONCLUSIONS Although DRI are responsible for 30% of undifferentiated NMF cases in travellers, those are seldom recognized during the first clinical encounter. Empirical treatment with doxycycline should be considered in returning travellers with undifferentiated fever and negative tests for malaria and dengue, particularly when presenting severe illness, predictive factors for rickettsiosis or no features of dengue.
Collapse
Affiliation(s)
| | - José Antonio Oteo
- Center of Rickettsiosis and Arthropod-Borne Diseases, Hospital Universitario San Pedro-CIBIR, Logroño 26006, Spain
| | - Emmanuel Bottieau
- Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp 2000, Belgium
| | - Blaise Genton
- Swiss Tropical and Public Health Institute, Basel 4051, Switzerland
- Center for Primary Care and Public Health, University of Lausanne, 1011, Switzerland
| | | | - Aránzazu Portillo
- Center of Rickettsiosis and Arthropod-Borne Diseases, Hospital Universitario San Pedro-CIBIR, Logroño 26006, Spain
| | - Ludovico Cobuccio
- Swiss Tropical and Public Health Institute, Basel 4051, Switzerland
- Center for Primary Care and Public Health, University of Lausanne, 1011, Switzerland
| | | | - Sonia Santibáñez
- Center of Rickettsiosis and Arthropod-Borne Diseases, Hospital Universitario San Pedro-CIBIR, Logroño 26006, Spain
| | - Dániel Cadar
- Bernhard Nocht Institute for Tropical Medicine, National Reference Centre for Tropical Pathogens, Hamburg 20359, Germany
| | | | - Alex Almuedo-Riera
- ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona 08036, Spain
| | - Carme Subirà
- ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona 08036, Spain
| | - Valérie d'Acremont
- Swiss Tropical and Public Health Institute, Basel 4051, Switzerland
- Center for Primary Care and Public Health, University of Lausanne, 1011, Switzerland
| | | | - Montserrat Roldán
- ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona 08036, Spain
| | | | - Marjan Van Esbroeck
- Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp 2000, Belgium
| | - Jose Muñoz
- ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona 08036, Spain
| |
Collapse
|
13
|
Can Modern Molecular Modeling Methods Help Find the Area of Potential Vulnerability of Flaviviruses? Int J Mol Sci 2022; 23:ijms23147721. [PMID: 35887069 PMCID: PMC9316223 DOI: 10.3390/ijms23147721] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2022] [Revised: 07/09/2022] [Accepted: 07/11/2022] [Indexed: 02/05/2023] Open
Abstract
Flaviviruses are single-stranded RNA viruses that have emerged in recent decades and infect up to 400 million people annually, causing a variety of potentially severe pathophysiological processes including hepatitis, encephalitis, hemorrhagic fever, tissues and capillaries damage. The Flaviviridae family is represented by four genera comprising 89 known virus species. There are no effective therapies available against many pathogenic flaviviruses. One of the promising strategies for flavivirus infections prevention and therapy is the use of neutralizing antibodies (NAb) that can disable the virus particles from infecting the host cells. The envelope protein (E protein) of flaviviruses is a three-domain structure that mediates the fusion of viral and host membranes delivering the infectious material. We previously developed and characterized 10H10 mAb which interacts with the E protein of the tick-borne encephalitis virus (TBEV) and many other flaviviruses’ E proteins. The aim of this work was to analyze the structure of E protein binding sites recognized by the 10H10 antibody, which is reactive with different flavivirus species. Here, we present experimental data and 3D modeling indicating that the 10H10 antibody recognizes the amino acid sequence between the two cysteines C92-C116 of the fusion loop (FL) region of flaviviruses’ E proteins. Overall, our results indicate that the antibody-antigen complex can form a rigid or dynamic structure that provides antibody cross reactivity and efficient interaction with the fusion loop of E protein.
Collapse
|
14
|
Navarro Valencia V, Díaz Y, Pascale JM, Boni MF, Sanchez-Galan JE. Assessing the Effect of Climate Variables on the Incidence of Dengue Cases in the Metropolitan Region of Panama City. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:ijerph182212108. [PMID: 34831862 PMCID: PMC8619576 DOI: 10.3390/ijerph182212108] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 11/08/2021] [Accepted: 11/09/2021] [Indexed: 11/24/2022]
Abstract
The present analysis uses the data of confirmed incidence of dengue cases in the metropolitan region of Panama from 1999 to 2017 and climatic variables (air temperature, precipitation, and relative humidity) during the same period to determine if there exists a correlation between these variables. In addition, we compare the predictive performance of two regression models (SARIMA, SARIMAX) and a recurrent neural network model (RNN-LSTM) on the dengue incidence series. For this data from 1999–2014 was used for training and the three subsequent years of incidence 2015–2017 were used for prediction. The results show a correlation coefficient between the climatic variables and the incidence of dengue were low but statistical significant. The RMSE and MAPE obtained for the SARIMAX and RNN-LSTM models were 25.76, 108.44 and 26.16, 59.68, which suggest that any of these models can be used to predict new outbreaks. Although, it can be said that there is a limited role of climatic variables in the outputs the models. The value of this work is that it helps understand the behaviour of cases in a tropical setting as is the Metropolitan Region of Panama City, and provides the basis needed for a much needed early alert system for the region.
Collapse
Affiliation(s)
- Vicente Navarro Valencia
- Facultad de Ciencias y Tecnología, Universidad Tecnológica de Panamá (UTP), El Dorado 0819-07289, Panama;
| | - Yamilka Díaz
- Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Justo Arosemena Avenue and 35st Street, Panama 0816-02593, Panama;
| | - Juan Miguel Pascale
- Unit of Diagnosis, Clinical Research and Tropical Medicine, Gorgas Memorial Institute of Health Studies, Justo Arosemena Avenue and 35st Street, Panama 0816-02593, Panama;
- Sistema Nacional de Investigación (SNI) SENACYT, Panama 0816-02852, Panama
| | - Maciej F. Boni
- Center for Infectious Disease Dynamics, Department of Biology, Pennsylvania State University, University Park, PA 16802, USA;
| | - Javier E. Sanchez-Galan
- Facultad de Ciencias y Tecnología, Universidad Tecnológica de Panamá (UTP), El Dorado 0819-07289, Panama;
- Sistema Nacional de Investigación (SNI) SENACYT, Panama 0816-02852, Panama
- Grupo de Investigaciones en Biotecnología, Bioinformática y Biología de Sistemas (GIBBS), Facultad de Ingenieria de Sistemas Computacionales, Universidad Tecnológica de Panamá (UTP), El Dorado 0819-07289, Panama
- Correspondence: ; Tel.: +507-560-3933
| |
Collapse
|
15
|
Barros AM, Martins-de-Barros AV, Costa MJ, Sette-de-Souza PH, Lucena EE, Araújo FA. Prevalence of ulcerative stomatitis in arbovirus infections in a Brazilian Northeast population. Med Oral Patol Oral Cir Bucal 2020; 25:e810-e817. [PMID: 33037807 PMCID: PMC7648917 DOI: 10.4317/medoral.23865] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2020] [Accepted: 09/03/2020] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Although there are no population-based studies that support an association, there are reports in the literature of mucocutaneous, vesiculobullous and ulcerated lesions in the oral mucosa in cases of arbovirus infection. The aim of this study is to analyze the prevalence of ulcerative stomatitis in individuals affected by arboviruses in a population of the municipality of Arcoverde, Pernambuco, Brazil. MATERIAL AND METHODS 1,003 people living in an area assigned to a Primary Health Care Unit were interviewed. A structured questionnaire was used for data collection, with questions about sociodemographic variables, residence conditions, general health information, as well as information about the general signs and symptoms of arboviruses and specifically about oral lesions. RESULTS Of the 1,003 individuals interviewed, 815 (81.25%) were infected by one or more arboviruses. Of these, 147 (18%) reported ulcerated oral lesions during arbovirus infections. The association between arbovirus infections and the presence of ulcerated oral lesions was statistically significant (p = 0.000). CONCLUSIONS In these cases, the ulcerated lesions on the oral mucosa appear to be associated with arbovirus infection, especially Chikungunya, although the pathophysiological mechanisms are not defined, and the studies are not sufficient to confirm this association.
Collapse
Affiliation(s)
- A-M Barros
- Department of Oral and Maxillofacial Surgery Hospital Universitário Oswaldo Cruz University of Pernambuco, Campus Santo Amaro Rua Arnóbio Marquês, 310, Santo Amaro, Recife, Pernambuco, Brazil
| | | | | | | | | | | |
Collapse
|
16
|
Esser HJ, Liefting Y, Ibáñez-Justicia A, van der Jeugd H, van Turnhout CAM, Stroo A, Reusken CBEM, Koopmans MPG, de Boer WF. Spatial risk analysis for the introduction and circulation of six arboviruses in the Netherlands. Parasit Vectors 2020; 13:464. [PMID: 32912330 PMCID: PMC7488554 DOI: 10.1186/s13071-020-04339-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2020] [Accepted: 09/01/2020] [Indexed: 12/18/2022] Open
Abstract
Background Arboviruses are a growing public health concern in Europe, with both endemic and exotic arboviruses expected to spread further into novel areas in the next decades. Predicting where future outbreaks will occur is a major challenge, particularly for regions where these arboviruses are not endemic. Spatial modelling of ecological risk factors for arbovirus circulation can help identify areas of potential emergence. Moreover, combining hazard maps of different arboviruses may facilitate a cost-efficient, targeted multiplex-surveillance strategy in areas where virus transmission is most likely. Here, we developed predictive hazard maps for the introduction and/or establishment of six arboviruses that were previously prioritized for the Netherlands: West Nile virus, Japanese encephalitis virus, Rift Valley fever virus, tick-borne encephalitis virus, louping-ill virus and Crimean-Congo haemorrhagic fever virus. Methods Our spatial model included ecological risk factors that were identified as relevant for these arboviruses by an earlier systematic review, including abiotic conditions, vector abundance, and host availability. We used geographic information system (GIS)-based tools and geostatistical analyses to model spatially continuous datasets on these risk factors to identify regions in the Netherlands with suitable ecological conditions for arbovirus introduction and establishment. Results The resulting hazard maps show that there is spatial clustering of areas with either a relatively low or relatively high environmental suitability for arbovirus circulation. Moreover, there was some overlap in high-hazard areas for virus introduction and/or establishment, particularly in the southern part of the country. Conclusions The similarities in environmental suitability for some of the arboviruses provide opportunities for targeted sampling of vectors and/or sentinel hosts in these potential hotspots of emergence, thereby increasing the efficient use of limited resources for surveillance.![]()
Collapse
Affiliation(s)
- Helen Joan Esser
- Wildlife Ecology & Conservation Group, Wageningen University & Research, Wageningen, The Netherlands. .,Laboratory of Entomology, Wageningen University & Research, Wageningen, The Netherlands. .,Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
| | - Yorick Liefting
- Wildlife Ecology & Conservation Group, Wageningen University & Research, Wageningen, The Netherlands
| | - Adolfo Ibáñez-Justicia
- Centre for Monitoring of Vectors (CMV), National Reference Centre (NRC), Netherlands Food and Consumer Product Safety Authority (NVWA), Ministry of Agriculture, Nature and Food Quality, Wageningen, The Netherlands
| | - Henk van der Jeugd
- Vogeltrekstation - Dutch Centre for Avian Migration and Demography (NIOO-KNAW), Wageningen, The Netherlands
| | - Chris A M van Turnhout
- Sovon Dutch Centre for Field Ornithology, Nijmegen, The Netherlands.,Department of Animal Ecology & Ecophysiology, Institute for Water and Wetland Research, Radboud University, Nijmegen, The Netherlands
| | - Arjan Stroo
- Centre for Monitoring of Vectors (CMV), National Reference Centre (NRC), Netherlands Food and Consumer Product Safety Authority (NVWA), Ministry of Agriculture, Nature and Food Quality, Wageningen, The Netherlands
| | - Chantal B E M Reusken
- Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.,Department of Viroscience, WHO CC for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Marion P G Koopmans
- Department of Viroscience, WHO CC for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Willem Fred de Boer
- Wildlife Ecology & Conservation Group, Wageningen University & Research, Wageningen, The Netherlands
| |
Collapse
|
17
|
Clé M, Eldin P, Briant L, Lannuzel A, Simonin Y, Van de Perre P, Cabié A, Salinas S. Neurocognitive impacts of arbovirus infections. J Neuroinflammation 2020; 17:233. [PMID: 32778106 PMCID: PMC7418199 DOI: 10.1186/s12974-020-01904-3] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2020] [Accepted: 07/17/2020] [Indexed: 12/15/2022] Open
Abstract
Arthropod-borne viruses or arbovirus, are most commonly associated with acute infections, resulting on various symptoms ranging from mild fever to more severe disorders such as hemorrhagic fever. Moreover, some arboviral infections can be associated with important neuroinflammation that can trigger neurological disorders including encephalitis, paralysis, ophthalmological impairments, or developmental defects, which in some cases, can lead to long-term defects of the central nervous system (CNS). This is well illustrated in Zika virus-associated congenital brain malformations but also in West Nile virus-induced synaptic dysfunctions that can last well beyond infection and lead to cognitive deficits. Here, we summarize clinical and mechanistic data reporting on cognitive disturbances triggered by arboviral infections, which may highlight growing public health issues spanning the five continents.
Collapse
Affiliation(s)
- Marion Clé
- Pathogenesis and Control of Chronic Infections, INSERM, University of Montpellier, Etablissement Français du Sang, Montpellier, France
| | - Patrick Eldin
- Institute of Research in Infectiology of Montpellier, CNRS, University of Montpellier, Montpellier, France
| | - Laurence Briant
- Institute of Research in Infectiology of Montpellier, CNRS, University of Montpellier, Montpellier, France
| | - Annie Lannuzel
- Neurology Unit, INSERM CIC 1424, Guadeloupe University Hospital, Université des Antilles, Pointe-à-Pitre, Guadeloupe, France
- INSERM U1127, CNRS, UMR7225, Brain and Spine Institute, Sorbonne University Medical School, Paris, France
| | - Yannick Simonin
- Pathogenesis and Control of Chronic Infections, INSERM, University of Montpellier, Etablissement Français du Sang, Montpellier, France
| | - Philippe Van de Perre
- Pathogenesis and Control of Chronic Infections, INSERM, University of Montpellier, Etablissement Français du Sang, CHU Montpellier, Montpellier, France
| | - André Cabié
- INSERM CIC 1424, Infectious Disease and Tropical Medicine Unit, Martinique University Hospital, Université des Antilles EA4537, Martinique, France.
| | - Sara Salinas
- Pathogenesis and Control of Chronic Infections, INSERM, University of Montpellier, Etablissement Français du Sang, Montpellier, France.
| |
Collapse
|
18
|
Mäkelä HMM, Cristea V, Sane JA. Lack of perception regarding risk of dengue and day-active mosquitoes in Finnish travellers. Infect Dis (Lond) 2020; 52:651-658. [PMID: 32538285 DOI: 10.1080/23744235.2020.1775883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Abstract
Background: An increasing number of international travellers are at risk for dengue infection. We analysed the characteristics of Finnish travellers with recently acquired dengue infections.Methods: Notified dengue infections from 2016 to 2019 were obtained from the Finnish National Infectious Disease Register. We developed a questionnaire and invited individuals diagnosed with dengue to provide information on countries and areas of infection, travel characteristics, risk perception and use of protective measures.Results: Almost all infections (94%, 127/135) were acquired in Asian countries, most in Thailand (78/135, 58%). The Maldives had the highest crude risk after adjusting for the number of travellers (55.6/100,000). Most trips were pre-booked holidays (93/111, 84%) and 62% (69/111) had a duration of 14-21 days with time spent mostly on the beach (78/111, 70%). The majority of travellers were not aware of the risk of dengue infection before travelling (67/111, 60%) and had not sought pre-travel advice (72/111, 65%). The majority applied some protective measures (71/111, 64%) but mainly after sunset (64/111, 58%).Conclusions: Most dengue infections in Finnish travellers were acquired at popular destinations in Southeast Asia, especially Thailand. Our study showed that there was low awareness regarding the risk of contracting the infection. In addition, many travellers reported inadequate use of protective measures. This calls for further public health actions, such as raising awareness of day-active mosquitoes, of risk at popular travelling destinations and the correct way of applying anti-vectorial measures.
Collapse
Affiliation(s)
- Henna M M Mäkelä
- Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
| | - Veronica Cristea
- Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.,European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden
| | - Jussi A Sane
- Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
| |
Collapse
|
19
|
Caputo B, Manica M, Russo G, Solimini A. Knowledge, Attitude and Practices towards the Tiger Mosquito Aedes Albopictus. A Questionnaire Based Survey in Lazio Region (Italy) before the 2017 Chikungunya Outbreak. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2020; 17:ijerph17113960. [PMID: 32503246 PMCID: PMC7312532 DOI: 10.3390/ijerph17113960] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 05/25/2020] [Accepted: 05/30/2020] [Indexed: 12/18/2022]
Abstract
The invasion of Aedes albopictus has played a major role in the resurgence of mosquito-borne diseases in Italy, generating the two largest chikungunya outbreaks in Europe (2007, 2017). Knowledge, attitude and practice (KAP) are important in order to prevent Aedes-borne disease transmission, yet so far they have not been assessed. To this scope we used multivariate logistic regression to investigate KAP of citizen-to-Aedes ecology and transmitted diseases. Data were collated by a structured questionnaire (18 questions) in 2016. Participants were selected in the Lazio region from members of native populations and two resident communities (RC) originating from the Indian subcontinent where Aedes-transmitted diseases are endemic. Results showed that compared to Italians, RC respondents had a higher knowledge and concern of Aedes-transmitted diseases (Odds Ratio = 2.61 (95%CI: 1.03–6.05); OR = 3.13 (2.15–4.65)) as well as their life cycles (OR = 2.49 (1.75–3.56); OR = 9.04 (6.22–13.66)). In contrast, they perceived a lower nuisance due to the presence of Ae. albopictus (OR = 0.2 (0.13–0.32); OR = 0.55 (0.38–0.78). These findings suggest that citizens in the Lazio region are not prepared to face a potential outbreak of arboviruses and further efforts should be made to increase knowledge, awareness and best practices.
Collapse
Affiliation(s)
- Beniamino Caputo
- Department of Public Health & Infectious Diseases, University of Roma “La Sapienza”, 00185 Rome, Italy; (B.C.); (G.R.)
| | - Mattia Manica
- Department of Biodiversity and Molecular Ecology, Research and Innovation Centre, Fondazione Edmund Mach, 38010 San Michele all’Adige, Italy;
| | - Gianluca Russo
- Department of Public Health & Infectious Diseases, University of Roma “La Sapienza”, 00185 Rome, Italy; (B.C.); (G.R.)
| | - Angelo Solimini
- Department of Public Health & Infectious Diseases, University of Roma “La Sapienza”, 00185 Rome, Italy; (B.C.); (G.R.)
- Correspondence:
| |
Collapse
|
20
|
Jourdain F, Roiz D, de Valk H, Noël H, L’Ambert G, Franke F, Paty MC, Guinard A, Desenclos JC, Roche B. From importation to autochthonous transmission: Drivers of chikungunya and dengue emergence in a temperate area. PLoS Negl Trop Dis 2020; 14:e0008320. [PMID: 32392224 PMCID: PMC7266344 DOI: 10.1371/journal.pntd.0008320] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2020] [Revised: 06/02/2020] [Accepted: 04/24/2020] [Indexed: 01/03/2023] Open
Abstract
BACKGROUND The global spread of Aedes albopictus has exposed new geographical areas to the risk of dengue and chikungunya virus transmission. Several autochthonous transmission events have occurred in recent decades in Southern Europe and many indicators suggest that it will become more frequent in this region in the future. Environmental, socioeconomic and climatic factors are generally considered to trigger the emergence of these viruses. Accordingly, a greater knowledge of the determinants of this emergence in a European context is necessary to develop adapted surveillance and control strategies, and public health interventions. METHODOLOGY/PRINCIPAL FINDINGS Using French surveillance data collected from between 2010 and 2018 in areas of Southern France where Ae. albopictus is already established, we assessed factors associated with the autochthonous transmission of dengue and chikungunya. Cases leading to autochthonous transmission were compared with those without subsequent transmission using binomial regression. We identified a long reporting delay (≥ 21 days) of imported cases to local health authorities as the main driver for autochthonous transmission of dengue and chikungunya in Southern France. The presence of wooded areas around the cases' place of residence and the accumulation of heat during the season also increased the risk of autochthonous arbovirus transmission. CONCLUSIONS Our findings could inform policy-makers when developing strategies to the emerging threats of dengue and chikungunya in Southern Europe and can be extrapolated in this area to other viruses such as Zika and yellow fever, which share the same vector. Furthermore, our results allow a more accurate characterization of the environments most at risk, and highlight the importance of implementing surveillance systems which ensure the timely reporting and of imported cases and swift interventions.
Collapse
Affiliation(s)
- Frédéric Jourdain
- Santé publique France (French National Public Health Agency), Saint-Maurice, France
- MIVEGEC Unit, IRD 224, CNRS 5290, Univ Montpellier, Montpellier, France
| | - David Roiz
- MIVEGEC Unit, IRD 224, CNRS 5290, Univ Montpellier, Montpellier, France
| | - Henriette de Valk
- Santé publique France (French National Public Health Agency), Saint-Maurice, France
| | - Harold Noël
- Santé publique France (French National Public Health Agency), Saint-Maurice, France
| | - Grégory L’Ambert
- Entente interdépartementale pour la démoustication du littoral méditerranéen (EID Méditerranée), Montpellier, France
| | - Florian Franke
- Santé publique France (French National Public Health Agency), Marseille, France
| | - Marie-Claire Paty
- Santé publique France (French National Public Health Agency), Saint-Maurice, France
| | - Anne Guinard
- Santé publique France (French National Public Health Agency), Toulouse, France
| | | | - Benjamin Roche
- MIVEGEC Unit, IRD 224, CNRS 5290, Univ Montpellier, Montpellier, France
| |
Collapse
|
21
|
Schulz C, Gabriel G, von Köckritz-Blickwede M. Detrimental Role of Neutrophil Extracellular Traps during Dengue Virus Infection. Trends Immunol 2019; 41:3-6. [PMID: 31791719 DOI: 10.1016/j.it.2019.11.010] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2019] [Accepted: 11/15/2019] [Indexed: 12/27/2022]
Abstract
A recent article by Sung et al. identified the CLEC2 platelet receptor as an important factor of lethal dengue virus infection. Formation of neutrophil extracellular traps via crosstalk with CLEC5A and TLR2 neutrophils were ascribed a causative role in DENV infection. This provides new insights for the development of candidate broad-spectrum therapies against hemorrhagic virus infections.
Collapse
Affiliation(s)
- Claudia Schulz
- Research Center for Emerging Infections and Zoonosis, University of Veterinary Medicine, Hannover, Germany
| | - Gülsah Gabriel
- Viral Zoonosis-One Health, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany; Institute of Virology, University of Veterinary Medicine, Hannover, Germany
| | - Maren von Köckritz-Blickwede
- Research Center for Emerging Infections and Zoonosis, University of Veterinary Medicine, Hannover, Germany; Department of Physiological Chemistry, University of Veterinary Medicine Hannover, Hannover, Germany.
| |
Collapse
|
22
|
Sigfrid L, Perfect C, Rojek A, Longuere KS, Lipworth S, Harriss E, Lee J, Salam A, Carson G, Goossens H, Horby P. A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections. BMC Med 2019; 17:170. [PMID: 31488138 PMCID: PMC6729038 DOI: 10.1186/s12916-019-1387-5] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/21/2019] [Accepted: 07/09/2019] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND The epidemiology of CNS infections in Europe is dynamic, requiring that clinicians have access to up-to-date clinical management guidelines (CMGs) to aid identification of emerging infections and for improving quality and a degree of standardisation in diagnostic and clinical management practices. This paper presents a systematic review of CMGs for community-acquired CNS infections in Europe. METHODS A systematic review. Databases were searched from October 2004 to January 2019, supplemented by an electronic survey distributed to 115 clinicians in 33 European countries through the CLIN-Net clinical network of the COMBACTE-Net Innovative Medicines Initiative. Two reviewers screened records for inclusion, extracted data and assessed the quality using the AGREE II tool. RESULTS Twenty-six CMGs were identified, 14 addressing bacterial, ten viral and two both bacterial and viral CNS infections. Ten CMGs were rated high quality, 12 medium and four low. Variations were identified in the definition of clinical case definitions, risk groups, recommendations for differential diagnostics and antimicrobial therapy, particularly for paediatric and elderly populations. CONCLUSION We identified variations in the quality and recommendations of CMGs for community-acquired CNS infections in use across Europe. A harmonised European "framework-CMG" with adaptation to local epidemiology and risks may improve access to up-to-date CMGs and the early identification and management of (re-)emerging CNS infections with epidemic potential.
Collapse
Affiliation(s)
- Louise Sigfrid
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
| | - Chelsea Perfect
- University of North Carolina School of Medicine, Chapel Hill, NC, USA
| | - Amanda Rojek
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | | | - Sam Lipworth
- Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Eli Harriss
- Bodleian Health Care Libraries, University of Oxford, Oxford, UK
| | - James Lee
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Alex Salam
- United Kingdom Public Health Rapid Support Team, London, UK
| | - Gail Carson
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | | | - Peter Horby
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| |
Collapse
|
23
|
Fouque F, Reeder JC. Impact of past and on-going changes on climate and weather on vector-borne diseases transmission: a look at the evidence. Infect Dis Poverty 2019; 8:51. [PMID: 31196187 PMCID: PMC6567422 DOI: 10.1186/s40249-019-0565-1] [Citation(s) in RCA: 73] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2018] [Accepted: 06/03/2019] [Indexed: 12/30/2022] Open
Abstract
Background The climate variables that directly influence vector-borne diseases’ ecosystems are mainly temperature and rainfall. This is not only because the vectors bionomics are strongly dependent upon these variables, but also because most of the elements of the systems are impacted, such as the host behavior and development and the pathogen amplification. The impact of the climate changes on the transmission patterns of these diseases is not easily understood, since many confounding factors are acting together. Consequently, knowledge of these impacts is often based on hypothesis derived from mathematical models. Nevertheless, some direct evidences can be found for several vector-borne diseases. Main body Evidences of the impact of climate change are available for malaria, arbovirus diseases such as dengue, and many other parasitic and viral diseases such as Rift Valley Fever, Japanese encephalitis, human African trypanosomiasis and leishmaniasis. The effect of temperature and rainfall change as well as extreme events, were found to be the main cause for outbreaks and are alarming the global community. Among the main driving factors, climate strongly influences the geographical distribution of insect vectors, which is rapidly changing due to climate change. Further, in both models and direct evidences, climate change is seen to be affecting vector-borne diseases more strikingly in fringe of different climatic areas often in the border of transmission zones, which were once free of these diseases with human populations less immune and more receptive. The impact of climate change is also more devastating because of the unpreparedness of Public Health systems to provide adequate response to the events, even when climatic warning is available. Although evidences are strong at the regional and local levels, the studies on impact of climate change on vector-borne diseases and health are producing contradictory results at the global level. Conclusions In this paper we discuss the current state of the results and draw on evidences from malaria, dengue and other vector-borne diseases to illustrate the state of current thinking and outline the need for further research to inform our predictions and response. Electronic supplementary material The online version of this article (10.1186/s40249-019-0565-1) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Florence Fouque
- UNICEF/UNDP/ World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), 20 Avenue Appia, 1211, Geneva 27, Switzerland.
| | - John C Reeder
- UNICEF/UNDP/ World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), 20 Avenue Appia, 1211, Geneva 27, Switzerland
| |
Collapse
|
24
|
Testicular Degeneration and Infertility following Arbovirus Infection. J Virol 2018; 92:JVI.01131-18. [PMID: 30021901 PMCID: PMC6146814 DOI: 10.1128/jvi.01131-18] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2018] [Accepted: 07/16/2018] [Indexed: 01/01/2023] Open
Abstract
Arboviruses can cause a variety of clinical signs, including febrile illness, arthritis, encephalitis, and hemorrhagic fever. The recent Zika epidemic highlighted the possibility that arboviruses may also negatively affect the male reproductive tract. In this study, we focused on bluetongue virus (BTV), the causative agent of bluetongue and one of the major arboviruses of ruminants. We show that rams that recovered from bluetongue displayed signs of testicular degeneration and azoospermia up to 100 days after the initial infection. Importantly, testicular degeneration was induced in rams experimentally infected with either a high (BTV-1IT2006)- or a low (BTV-1IT2013)-virulence strain of BTV. Rams infected with the low-virulence BTV strain displayed testicular lesions in the absence of other major clinical signs. Testicular lesions in BTV-infected rams were due to viral replication in the endothelial cells of the peritubular areas of the testes, resulting in stimulation of a type I interferon response, reduction of testosterone biosynthesis by Leydig cells and destruction of Sertoli cells and the blood-testis barrier in more severe cases. Hence, BTV induces testicular degeneration and disruption of spermatogenesis by replicating solely in the endothelial cells of the peritubular areas unlike other gonadotropic viruses. This study shows that a naturally occurring arboviral disease can cause testicular degeneration and affect male fertility at least temporarily.IMPORTANCE During the recent Zika epidemic, it has become apparent that arboviruses could potentially cause reproductive health problems in male patients. Little is known regarding the effects that arboviruses have on the male reproductive tract. Here, we studied bluetongue virus (BTV), an arbovirus of ruminants, and its effects on the testes of rams. We show that BTV was able to induce testicular degeneration in naturally and experimentally infected rams. Testicular degeneration was caused by BTV replication in the endothelial cells of the peritubular area surrounding the seminiferous tubules (the functional unit of the testes) and was associated with a localized type I interferon response, destruction of the cells supporting the developing germinal cells (Sertoli cells), and reduction of testosterone synthesis. As a result of BTV infection, rams became azoospermic. This study highlights that problems in the male reproductive tract caused by arboviruses could be more common than previously thought.
Collapse
|
25
|
Ciocchetta S, Prow NA, Darbro JM, Frentiu FD, Savino S, Montarsi F, Capelli G, Aaskov JG, Devine GJ. The new European invader Aedes (Finlaya) koreicus: a potential vector of chikungunya virus. Pathog Glob Health 2018; 112:107-114. [PMID: 29737236 PMCID: PMC6056824 DOI: 10.1080/20477724.2018.1464780] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Arthropod-borne disease outbreaks, facilitated by the introduction of exotic mosquitoes, pose a significant public health threat. Recent chikungunya virus (CHIKV) epidemics in Europe highlight the importance of understanding the vector potential of invading mosquitoes. In this paper we explore the potential of Aedes koreicus, a mosquito new to Europe, to transmit CHIKV. Mosquitoes were challenged with CHIKV and maintained at two temperatures: 23 °C and a fluctuating temperature. Total CHIKV infection rates at 3, 10 and 14 days post-feeding were low for both temperature treatments (13.8% at 23 °C; 6.2% at fluctuating T). A low percentage (6.1%, n = 65) of mosquitoes maintained at a constant 23 °C showed dissemination of the virus to the wings and legs. Infection of mosquito saliva, with live virus, occurred in 2 mosquitoes. No dissemination was noted under the fluctuating temperature regime. Based on these results we conclude that CHIKV transmission by this species is possible.
Collapse
Affiliation(s)
- Silvia Ciocchetta
- QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Australia
- Institute for Health and Biomedical Innovation, and School of Biomedical Science, Queensland University of Technology, Brisbane, Australia
| | - Natalie A. Prow
- QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Australia
| | - Jonathan M. Darbro
- QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Australia
| | - Francesca D. Frentiu
- Institute for Health and Biomedical Innovation, and School of Biomedical Science, Queensland University of Technology, Brisbane, Australia
| | - Sandro Savino
- Geographic Information Systems, Department of Information Engineering, University of Padua, Padua, Italy
| | | | - Gioia Capelli
- Istituto Zooprofilattico Sperimentale delle Venezie, Padua, Italy
| | - John G. Aaskov
- Institute for Health and Biomedical Innovation, and School of Biomedical Science, Queensland University of Technology, Brisbane, Australia
| | - Gregor J. Devine
- QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Australia
| |
Collapse
|
26
|
Petersen E, Petrosillo N, Koopmans M. Emerging infections-an increasingly important topic: review by the Emerging Infections Task Force. Clin Microbiol Infect 2018; 24:369-375. [PMID: 29155018 PMCID: PMC7129920 DOI: 10.1016/j.cmi.2017.10.035] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2017] [Revised: 10/20/2017] [Accepted: 10/30/2017] [Indexed: 12/11/2022]
Abstract
OBJECTIVES This paper review trends in emerging infections and the need for increased clinical and laboratory surveillance. METHODS Factors that contributed to the emergence of recent outbreaks have been reviewed. Known, major outbreaks over the past two decades were reviewed. RESULTS We identified at least four major drivers of emergent infections: (i) increasing density of the human population; (ii) stress from farmland expansion on the environment; (iii) globalization of the food market and manufacturing; (iv) environmental contamination. The factors creating new opportunities for emerging infections include: (i) population growth; (ii) spread in health care facilities; (iii) an ageing population; (iv) international travel; (v) changing and expanding vector habitats. CONCLUSIONS Emerging infections are unpredictable. In this review we argue that to discover new trends in infectious diseases, the clinicians have to look for the unusual and unexpected and ensure proper diagnostics and that syndromic surveillance must be supported by highly specialized laboratory services. Mathematical modeling has not been able to predict outbreaks More emphasis on the biology of evolution is needed. EID rarely stands out as unusual, and the continuous pressure on health care budgets forces clinicians and laboratories to prioritize their diagnostic work-up to common and treatable conditions. The European Society for Infectious Diseases and Clinical Microbiology, ESCMID, has established an Emerging Infections Task Force, EITaF, to strengthen the activities of the society on emerging infections and ensure that emerging infections is included in differential diagnostic considerations in everyday clinical practice.
Collapse
Affiliation(s)
- E Petersen
- Institute for Clinical Medicine, University of Aarhus, Denmark and Department of Infectious Diseases, The Royal Hospital, Muscat, Oman.
| | - N Petrosillo
- Clinical and Research Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani', IRCCS, Rome, Italy
| | - M Koopmans
- Viroscience Department, Erasmus University of Rotterdam, The Netherlands
| |
Collapse
|
27
|
Sigfrid L, Eckerle I, Papa A, Horby P, Koopmans M, Reusken C. Strengthening preparedness for (re-) emerging arboviruses in Europe. Clin Microbiol Infect 2018; 24:219-220. [DOI: 10.1016/j.cmi.2018.02.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
28
|
Emerging souvenirs-clinical presentation of the returning traveller with imported arbovirus infections in Europe. Clin Microbiol Infect 2018; 24:240-245. [PMID: 29339224 DOI: 10.1016/j.cmi.2018.01.007] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2017] [Revised: 01/04/2018] [Accepted: 01/05/2018] [Indexed: 12/13/2022]
Abstract
BACKGROUND Arboviruses are an emerging group of viruses that are causing increasing health concerns globally, including in Europe. Clinical presentation usually consists of a nonspecific febrile illness that may be accompanied by rash, arthralgia and arthritis, with or without neurological or haemorrhagic syndromes. The range of differential diagnoses of other infectious and noninfectious aetiologies is broad, presenting a challenge for physicians. While knowledge of the geographical distribution of pathogens and the current epidemiological situation, incubation periods, exposure risk factors and vaccination history can help guide the diagnostic approach, the nonspecific and variable clinical presentation can delay final diagnosis. AIMS AND SOURCES This narrative review aims to summarize the main clinical and laboratory-based findings of the three most common imported arboviruses in Europe. Evidence is extracted from published literature and clinical expertise of European arbovirus experts. CONTENT We present three cases that highlight similarities and differences between some of the most common travel-related arboviruses imported to Europe. These include a patient with chikungunya virus infection presenting in Greece, a case of dengue fever in Turkey and a travel-related case of Zika virus infection in Romania. IMPLICATIONS Early diagnosis of travel-imported cases is important to reduce the risk of localized outbreaks of tropical arboviruses such as dengue and chikungunya and the risk of local transmission from body fluids or vertical transmission. Given the global relevance of arboviruses and the continuous risk of (re)emerging arbovirus events, clinicians should be aware of the clinical syndromes of arbovirus fevers and the potential pitfalls in diagnosis.
Collapse
|
29
|
Mosquitoes as Arbovirus Vectors: From Species Identification to Vector Competence. PARASITOLOGY RESEARCH MONOGRAPHS 2018. [PMCID: PMC7122353 DOI: 10.1007/978-3-319-94075-5_9] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Mosquitoes and other arthropods transmit a large number of medically important pathogens, in particular viruses. These arthropod-borne viruses (arboviruses) include a wide variety of RNA viruses belonging to the Flaviviridae family (West Nile virus (WNV), Usutu virus (USUV), Dengue virus (DENV), Japanese encephalitis virus (JEV), Zika virus (ZIKV)), the Togaviridae family (Chikungunya virus (CHIKV)), and Bunyavirales order (Rift Valley fever virus (RVFV)) (please refer also to Table 9.1). Arboviral transmission to humans and livestock constitutes a major threat to public health and economy as illustrated by the emergence of ZIKV in the Americas, RVFV outbreaks in Africa, and the worldwide outbreaks of DENV. To answer the question if those viral pathogens also pose a risk to Europe, we need to first answer the key questions (summarized in Fig. 9.1):Who could contribute to such an outbreak? Information about mosquito species resident or imported, potential hosts and viruses able to infect vectors and hosts in Germany is needed. Where would competent mosquito species meet favorable conditions for transmission? Information on the minimum requirements for efficient replication of the virus in a given vector species and subsequent transmission is needed. How do viruses and vectors interact to facilitate transmission? Information on the vector immunity, vector physiology, vector genetics, and vector microbiomes is needed.
Collapse
|
30
|
Reusken CB, Ieven M, Sigfrid L, Eckerle I, Koopmans M. Laboratory preparedness and response with a focus on arboviruses in Europe. Clin Microbiol Infect 2017; 24:221-228. [PMID: 29274465 DOI: 10.1016/j.cmi.2017.12.010] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2017] [Revised: 12/08/2017] [Accepted: 12/12/2017] [Indexed: 12/29/2022]
Abstract
BACKGROUND The global health burden of arboviruses is continuously rising, which results in increasing pressure on local and (inter)national laboratory infrastructures. Timely and accurate diagnosis of cases is one of the main pillars for public health and clinical responses to an arbovirus emergence. AIMS AND SOURCES This narrative review aims to summarize recent advances and to identify needs in laboratory preparedness and response activities, with a focus on viruses transmitted by arthropods in Europe. The review is based on evidence extracted from PubMed searches, Public Health and clinical laboratory experiences from the authors and the authors' opinions substantiated by peer-reviewed scientific literature. CONTENT We illustrate the importance of inter-epidemic laboratory preparedness activities to ensure adequate Public Health and clinical responses. We describe the status of arbovirus endemicity and emergence in Europe thereby highlighting the need for preparedness for these viruses. We discuss the components and pitfalls of an adequate laboratory preparedness and response and the broader context of the current landscape of international research, clinical and laboratory preparedness networks. The complexity of arbovirus laboratory preparedness and response is described. IMPLICATIONS Outbreak preparedness plans need to look beyond national reference laboratories, to include first-line responding onsite hospital laboratories and plans for strengthening of such local capacity and capability as required depending on the nature of the outbreak. In particular, the diagnosis of arbovirus infections is complicated by the existence of geographic overlap of circulation of numerous arboviruses, the overlap in clinical manifestation between many arboviruses and other aetiologies and the existence of cross-reactivity between related arboviruses in serology testing. Inter-epidemic preparedness activities need strong national and international networks addressing these issues. However, the current mushrooming of European preparedness networks requires governance to bring the European preparedness and response to a next level.
Collapse
Affiliation(s)
- C B Reusken
- Department of Viroscience, WHO Collaborating Center for Arboviruses and Viral Haemorrhagic Fever Reference and Research, Erasmus University Medical Centre, Rotterdam, the Netherlands.
| | - M Ieven
- Department of Medical Microbiology, Antwerp University Hospital, Antwerp, Belgium; Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium
| | - L Sigfrid
- Centre for Tropical Medicine and Global Health, Nuffield Dept. of Medicine, University of Oxford, Oxford, UK
| | - I Eckerle
- Institut für Virologie. Universitätsklinikum Bonn, Bonn, Germany
| | - M Koopmans
- Department of Viroscience, WHO Collaborating Center for Arboviruses and Viral Haemorrhagic Fever Reference and Research, Erasmus University Medical Centre, Rotterdam, the Netherlands
| |
Collapse
|